171338-27-5,
(2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine,
UNII-EA5SX368WV,
(2R,3S)-2-[(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY]-3-(4-FLUOROPHENYL)MORPHOLINE,
EA5SX368WV,
2-(R)-[1-(R)-(3,5-Bis(trifluoromethyl)phenyl)ethoxy]-3-(S)-fluorophenylmorpholine[Aprepitant-M2],
(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine,
(2R,3S)-2-[(1R)-1-[3,5-BIS(TRIFLUOROMETHYL]ETHOXY]-3-(4-FLUOROPHENYL)MORPHOLINE,
[2R-[2aR*),3a]-2-[1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine,
2-(r)-[1-(r)-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(s)-fluorophenylmorpholine,
(2R,3S)-2-((R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-ETHOXY)-3-(4-FLUOROPHENYL)MORPHOLINE,
Morpholine/,
(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholine,
170729-79-0,
C20H19ClF7NO2,
SCHEMBL264332,
C20H18F7NO2,
CTK8B9243,
DTXSID00435818,
AFBDSAJOMZYQAI-CNOZUTPLSA-N,
BCPP000158,
ABP000758,
ANW-62261,
ZINC89224316,
AKOS015908996,
BCP9000960,
RTX-010545,
2-((1R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl) morpholine, (2R,3S)-,
AC-23962,
AJ-80790,
AK102292,
Morpholine, 2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-, (2R,3S)-,
AX8233831,
FT-0663537,
ST24034006,
Y0384,
Z3113,
338B275,
A811318,
J-010710,
I14-33196,
I14-37669,
(2r, 3s)-2-(1r)-1-3,5-bis(trifluoromethyl) phenyl),
[2r-[2|A(s*),3|A]]-2-[1-[3,5-bis(trifluoromethyl)phenyl],
(2r,3s)-2-[(1r)-1-[3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-morpholine,
(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine,
2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-(2R,3S)-morpholine,
2alpha-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3alpha-(4-fluorophenyl)morpholine,
[2r-[2|A(s*),3|A]]-2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)- morpholine,
cis(2R,3S)-2-(((1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethyl)oxy)-3-(4-fluorophenyl)morpholine,
morpholine,2-[(1r)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-, (2r,3s)-,
Morpholine,2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-,(2R,3S)-,
morpholine,2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-, [2r-[2a(r*),3a]]-,
morpholine,2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-[2r-[2a(s*),3a]],
Fmoc-allyl-Gly-OH,
Fmoc-D-2-allylglycine,
CID10113945,
(R)-N-(9-Fluorenylmethoxycarbonyl)-2-amino-4-pentenoic acid,
171482-05-6,
(2R,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine,
(1S,9S)-1-Amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-10H,13H-benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-10,13-dione,
(2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride,